Dendorfer, S. M., Schmidt-Brücken, K., Kramer, M., Steffen, B., Schliemann, C., Mikesch, J., . . . Röllig, C. (2026). Randomized comparison of cardiotoxicity with 60 versus 90 mg daunorubicin in AML induction therapy. American journal of hematology, 101(3), . https://doi.org/10.1002/ajh.70160
Chicago Style (17th ed.) CitationDendorfer, Stefan Markus, et al. "Randomized Comparison of Cardiotoxicity with 60 Versus 90 Mg Daunorubicin in AML Induction Therapy." American Journal of Hematology 101, no. 3 (2026). https://doi.org/10.1002/ajh.70160.
MLA (9th ed.) CitationDendorfer, Stefan Markus, et al. "Randomized Comparison of Cardiotoxicity with 60 Versus 90 Mg Daunorubicin in AML Induction Therapy." American Journal of Hematology, vol. 101, no. 3, 2026, https://doi.org/10.1002/ajh.70160.